AIT Therapeutics (AITB) Stock: Positioned To Propel Nitric Oxide Treatment Into The Mainstream

By |November 8th, 2017|

Investors, if you have not yet met AIT Therapeutics (AITB), consider yourself privileged to be provided an introduction. Now, although that prior statement may read as presumptuous, once investors get initiated to the premise that AITB sits ideally positioned to alter the therapeutic landscape for treating respiratory infection and pulmonary hypertension, the favorable opinion […]